$WOOF

Petco (WOOF) Q2 2026 Earnings Call Transcript

Petco (WOOF) reported Q2 2026 net sales of $1.49B, up 0.05% YoY, with comparable sales growth of 0.6%. Adjusted EBITDA was $122.2M, including $6.8M in tariff refunds. The company prepaid $75M in debt, reducing total debt to $1.48B. Full-year sales guidance remains flat to up 1.5%, with adjusted EBITDA guidance of $415M-$430M. Management noted softness in the dog category and supply chain headwinds.

Original reporting
Published Sep 9, 2026, 10:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 10:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Petco (WOOF) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$WOOFBullishMed
01

Why it matters

The earnings beat and debt reduction suggest a healthier balance sheet, but soft pet category sales and supply‑chain pressures remain concerns.

02

Market read

The earnings release offers fresh data for traders evaluating pet‑care stocks and consumer discretionary exposure.

03

What to watch

Potential supply‑chain headwinds from fuel and tariff costs may erode future profitability.

Relevance 8/10Novelty 8/10Timing: post‑market release

Background

Petco Health and Wellness Company, Inc. (WOOF) released its Q2 2026 earnings call, providing detailed financial metrics and guidance.

Company-level read

Ticker impact

$WOOFBullishHigh confidence
Context

Petco reported Q2 2026 results with modest sales growth, adjusted EBITDA of $122.2M and reaffirmed full-year guidance.

Expected impact

Potential modest upside as investors price in stronger cash flow and debt reduction.

Evidence & confidence

Guidance remains unchanged with improved cash metrics; market may reward the balance‑sheet discipline.

Market effects

Petco's performance may influence the broader pet‑care retail sector, highlighting demand for veterinary services.

U.S. pet‑care retailers could see modest valuation adjustments.

Limited, primarily U.S. consumer discretionary focus.

Counterpoint

Softness in the dog category and higher redemption costs could pressure margins if not managed.

Key entities

  • Petco Health and Wellness Company, Inc.

    U.S. pet‑care retailer reporting Q2 2026 results.

Related articles

$CHWYHighAI 8/10

Cat People vs. Dog People: Chewy’s CEO Reveals Who’s Spending More on Their Pets Right Now, and Who’s Cutting Back

Chewy (CHWY) and Petco (WOOF) reported stronger sales in cat products and weaker dog-related sales. General Mills (GIS) saw similar trends, with cat food sales up and dog food down. Cat ownership grew faster than dog ownership, with cats costing less overall. Chewy's Q2 sales rose 7.3% YoY, and it raised full-year guidance, but its stock is down 43.72% YTD.

$WOOFMed

Petco Is Still Being Priced Like the Old Petco

Petco reported improved free cash flow of $60.8M (up from $9.9M YoY) and reduced debt to $1.48B. The company prepaid $75M in debt, aiming for a 2x net debt to EBITDA target. Full-year guidance remains unchanged: net sales flat to +1.5%, adjusted EBITDA $415M-$430M. Q3 sales growth expected at 0.4%-1.0%, adjusted EBITDA $100M-$103M. CEO and CFO highlighted progress in consumables and debt reduction. Analysts' consensus price target is $3.42, a 32% upside, but ratings are mixed.

$WOOFHigh

WOOF Jumps As Petco EPS Beat Triggers Bullish Re‑Rating

Petco Health and Wellness (WOOF) shares rose 7.14% after Q2 earnings beat estimates ($0.13 EPS vs $0.05-$0.07 expected) and revenue of ~$1.5B. Analysts raised targets to $3.25-$4.00, citing turnaround progress, but note high debt and thin margins. Stock is consolidating near $2.70, with support at $2.50.

$WOOFHigh

WOOF Jumps As Petco Earnings Beat Sparks Turnaround Hopes

Petco Health and Wellness (WOOF) stock rose 7.14% after Q2 earnings beat expectations, with EPS at $0.13 vs. estimates of $0.05-$0.07. Revenue was flat YoY at ~$1.5B but slightly ahead of estimates. The company improved profitability and prepaid ~$170M of debt, addressing balance sheet concerns. Analysts see potential upside to $3.50 if margin expansion continues.